Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe site footer now identifies the website as revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe revision label updates from v3.6.6 to v3.7.0 in the study record history display, indicating a newer version of the page. This change is a metadata update and does not modify any study data or content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe history view now shows Revision: v3.6.6 instead of v3.6.5, indicating a small frontend update to the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe study record history shows new entries for Study Design and Study Status, indicating updates to the trial's design and its current status. An older history entry dated 2026-05-28 was removed.SummaryDifference0.2%

- Check69 days agoChange DetectedA new revision label v3.6.5 was added to the history, representing the latest page revision. This update supersedes the previous v3.6.4.SummaryDifference0.0%

- Check83 days agoChange DetectedThe revision history adds a new entry for Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor update to the page's version rather than a change to study data or content.SummaryDifference0.0%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.